Expert Review of Clinical Immunology 期刊简介
Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology.
Articles focus on the following key areas:
• Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines
• Performance and benefits of newly approved therapeutic agents
• New diagnostic approaches
• Screening and patient stratification
• Pharmacoeconomic studies
• New therapeutic indications for existing therapies
• Adverse effects, occurrence and reduction
• Prospects for medicines in late-stage trials approaching regulatory approval
• Novel treatment strategies
• Epidemiological studies
• Commentary and comparison of treatment guidelines
Topics include infection and immunity, inflammation, host defense mechanisms, congenital and acquired immunodeficiencies, anaphylaxis and allergy, systemic immune diseases, organ-specific inflammatory diseases, transplantation immunology, endocrinology and diabetes, cancer immunology, neuroimmunology and hematological diseases.
临床免疫学专家评论 (ISSN 1744-666X) 提供有关临床免疫学中新治疗和诊断方式的性能的专家分析和评论。临床免疫学专家评审国际编辑咨询小组的成员是其专业领域的最前沿。该小组与我们专门的编辑团队合作,确定最重要和主题的评论主题以及最适合提供评论和分析的相应专家。所有文章都经过严格的同行评审,完成的评审为临床免疫学的决策做出了重要贡献。
文章着重于以下关键领域:
• 特定免疫性疾病的治疗概述突出了最佳治疗和新药物的前景
• 新批准的治疗剂的性能和益处
• 新的诊断方法
• 筛查和患者分层
• 药物经济学研究
• 新的治疗方法现有疗法的适应症
• 不良反应,发生和减少
• 药物在接近监管批准的后期试验中的前景
• 新颖的治疗策略
• 流行病学研究
• 治疗指南的评论和比较
主题包括感染和免疫,炎症,宿主防御机制,先天性和获得性免疫缺陷,过敏反应和过敏,全身免疫性疾病,器官特异性炎症性疾病,移植免疫学,内分泌学和糖尿病,癌症免疫学,神经免疫学和血液系统疾病。
期刊ISSN
|
1744-666X |
影响指数
|
4.428 |
最新CiteScore值
|
7.00 查看CiteScore评价数据 |
最新自引率
|
2.80% |
官方指定润色网址
|
https://www.deeredit.com/?type=ss1 |
投稿语言要求
|
Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted. 建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率 |
期刊官方网址
hot |
https://www.peipusci.com/?type=9 |
杂志社征稿网址
hot |
https://www.peipusci.com/?type=10 |
通讯地址
|
EXPERT REVIEWS, UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB |
偏重的研究方向(学科)
|
IMMUNOLOGY- |
出版周期
|
Bimonthly |
出版年份
|
2005 |
出版国家/地区
|
UNITED STATES |
是否OA
|
No |
SCI期刊coverage
|
Science Citation Index Expanded(科学引文索引扩展) |
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
最新中科院JCR分区
|
大类(学科)
小类(学科)
综述期刊
医学
IMMUNOLOGY(免疫学)3区
是
|
|||||
最新的影响因子
|
4.428 | |||||
最新公布的期刊年发文量 |
|
|||||
总被引频次 | 42 | |||||
影响因子趋势图 |
近年的影响因子趋势图(整体平稳趋势)
|
2022年预警名单预测最新
最新CiteScore值
|
7.00
|
||||||||||||||
年文章数 | 106 | ||||||||||||||
SJR
|
1.235 | ||||||||||||||
SNIP
|
1.535 | ||||||||||||||
CiteScore排名
|
|
||||||||||||||
CiteScore趋势图 |
CiteScore趋势图
|
本刊同领域相关期刊
|
|
期刊名称 | IF值 |
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY | 2.026 |
AIDS | 4.135 |
APMIS | 3.173 |
VACCINE | 3.605 |
BIODRUGS | 5.749 |
IMMUNITY | 31.428 |
LYMPHOLOGY | 1.273 |
Lancet HIV | 12.639 |
AIDS REVIEWS | 2.475 |
本刊同分区等级的相关期刊
|
|
期刊名称 | IF值 |
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY | 2.026 |
VACCINE | 3.605 |
AIDS REVIEWS | 2.475 |
AUTOIMMUNITY | 2.787 |
TUBERCULOSIS | 3.1 |
IMMUNOBIOLOGY | 3.113 |
Immunotherapy | 4.154 |
BMC IMMUNOLOGY | 3.579 |
IMMUNOLOGY LETTERS | 3.648 |
分享者 | 点评内容 |